Eileen Rothrock
Nurse Practitioner · Huntingdon Valley, PANPI 1659440550
Payments from drug & device makers
Across 332 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$799
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$457
- GSK$286
- Johnson & Johnson$267
- Teva Pharmaceuticals USA, Inc.$263
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,637100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $1,369 |
| AstraZeneca | 49 | $799 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 43 | $457 |
| GSK | 21 | $286 |
| Johnson & Johnson | 15 | $267 |
| Teva Pharmaceuticals USA, Inc. | 11 | $263 |
| Braeburn Inc. | 12 | $249 |
| Indivior Inc. | 13 | $238 |
| Amgen | 14 | $236 |
| Alkermes, Inc. | 12 | $222 |
| Lilly USA, LLC | 11 | $197 |
| Neurocrine Biosciences, Inc. | 7 | $184 |
| Otsuka America Pharmaceutical, Inc. | 11 | $177 |
| Exact Sciences | 5 | $99 |
| E.r. Squibb & Sons, L.L.C. | 4 | $98 |
| Sunovion Pharmaceuticals Inc. | 3 | $65 |
| Lundbeck LLC | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Gilead | 4 | $51 |
| Astellas Pharma US Inc | 2 | $51 |
| Boehringer Ingelheim | 4 | $49 |
| Novo Nordisk | 2 | $45 |
| Verona Pharma, Inc. | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Merck | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Philips North America LLC | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Zealand Pharma US, Inc. | 1 | $14 |
| Pfizer | 1 | $12 |
How this compares
$5,664 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 22 | $54,334 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $49,449 |
| SublocadeBuprenorphine | 23 | $46,741 |
| MounjaroTirzepatide | 37 | $38,888 |
| Invega SustennaPaliperidone Palmitate | 12 | $30,460 |
| EliquisApixaban | 36 | $30,442 |
| TrulicityDulaglutide | 20 | $21,953 |
| JardianceEmpagliflozin | 18 | $16,596 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $15,149 |
| FarxigaDapagliflozin Propanediol | 13 | $12,342 |
| OzempicSemaglutide | 13 | $11,727 |
| LinzessLinaclotide | 16 | $11,433 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $8,406 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 52 | $5,964 |
| Atrovent HfaIpratropium Bromide | 11 | $5,074 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Olanzapine | $197 | $61,33076 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $286 | $57,85593 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $177 | $54,33422 claims |
| Indivior Inc.Sublocade, Suboxone | $238 | $50,18436 claims |
| Johnson & JohnsonInvega Sustenna | $267 | $30,46012 claims |
| PfizerEliquis | $12 | $30,44236 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $799 | $27,49031 claims |
| Boehringer IngelheimJardiance | $49 | $16,59618 claims |
| Novo NordiskOzempic | $45 | $11,72713 claims |
| AbbVieLinzess | $1,369 | $11,43316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Huntingdon Valley
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.